A more accurate diagnosis for women at risk of cervical cancer in Manchester
Central Manchester University Hospitals NHS Foundation Trust
(CMFT) is using pioneering new technology to improve the speed and
accuracy in diagnosing pre-cancerous conditions of the cervix.
The Trust has introduced the innovative cervical cancer
diagnostic system called ZedScan™ at the Gynaecology department at
Saint Mary's Hospital, Manchester - a centre of excellence in the
field of gynaecological oncology, uro-gynaecology and reproductive
ZedScan™ can measure and detect tissue changes in women
identified with an abnormal smear test.
The system offers real-time and more accurate detection of
pre-cancerous cells than standard colposcopy (a procedure for
examining the cervix), enabling clinicians to make better informed
decisions at a patient's first visit.
It means appropriate treatment can offered immediately to women
identified with severe abnormalities or reassurance swiftly
provided to patients with no evidence of disease, whilst also
reducing the number of biopsies required.
Dr Ursula Winters, Consultant Gynaecologist and lead consultant
for colposcopy at Saint Mary's, said:
"The introduction of Zedscan will provide us with the ability to
assess women presenting with abnormal cervical smears more quickly
"Having access to the latest in advanced diagnostic technologies
such as ZedScan means we can offer our patients efficient and rapid
access to appropriate treatments when they need them."
The technology behind the system was developed by Manchester
company Zilico Ltd, based at MedTech Centre Incubator, following a
collaboration between Professor Brian Brown, a medical physicist at
the University of Sheffield, and Professor John Tidy, a consultant
gynaecological oncologist at Sheffield Teaching Hospitals.
The ZedScan™ system, which uses its patented Electrical
Impedance Spectroscopy (EIS) technology to detect dysplasia and
cancer of the cervix, consists of a portable handset, docking
station, single use sensor and software application.
TRUSTECH, our innovation service provider has been working with
gynaecologists, the company Zilico and the Greater Manchester
Academic Health Science Network to evaluate and introduce the
technology into the NHS.